INTRODUCTION
Postoperative morbidity and mortality after hepatectomy are adversely affected by blood loss and blood transfusion. 1 There are several hemostatic methods to control bleeding. Mechanical techniques include manual pressure and ligation. Although these techniques are the oldest and most flexible method, they can be labor-intensive and add time to the operation. 2 Thermal methods, such as electrocauterization, laser cauterization, or argon beam, can also be useful methods. However, these methods create necrotic tissue, which increases the rate of infection and may lead to impaired healing. Furthermore, these conventional techniques and methods are sometimes difficult to apply because of difficulty in accessing the areas of bleeding. 3 Topical hemostatic agents may be useful in such situations. Currently, several hemostatic agents are commercially available. Broadly, these agents are one of two types: passive or active. Active agents, such as thrombin, fibrin sealants, and hemostatic patches, provide biologically active components of the coagulation cascade. In contrast, passive agents, such as oxidized regenerated cellulose, gelatin sponges, and collagen pads and sponges, cause the activation of the coagulation cascade. 4 Among the passive hemostatic agents, oxidized regenerated cellulose (ORC) has been in use for several decades. ORC contributes to hemostatic action by absorption of blood, surface interaction with platelets and proteins, and coagulation cascade activation. 5 Since ORC was first reported in 1943, several commercial products have been used. 6 Blood loss was measured at the time of exposing the resection margin after the confirmation of hemostasis.
MATERIALS AND METHODS

Material
Blood loss was measured for 5 minutes after the resection.
If bleeding was not stopped after 5 minutes, this was regarded as a failure of 1 st hemostasis, and blood loss was measured twice at every 2 minutes (i.e., 7 minutes and 9 minutes after resection). The control group received no topical treatment at the resection margin after liver After measurement of the blood loss, the surgical region was arranged to avoid adhesion with the resection margin of the liver. The muscle and skin were then sutured. The time of every procedure of the operation was recorded.
After surgery, the animals were permitted food and water as normal upon recovery from anesthesia. They were subsequently monitored once daily. If any abnormality was found, the type and date of occurrence and severity of signs were recorded for each abnormality. All animals were weighed once weekly throughout the experimental period. One week after the operation, a blood sample was taken to measure the same parameters determined preoperatively.
The animals in each study group (control, reference, and test) were randomly divided into 2 subgroups for necropsy. Two mini-pigs were allocated to 1 st necropsy group and the other 3 mini-pigs were allocated to 2 nd necropsy group. Necropsy was performed 4 weeks after the operation in the 1 st necropsy group and 6 weeks after surgery in 2 nd necropsy group. All mini-pigs were fasted before their necropsy for at least 12 hours. Before anesthesia, another set of blood samples was obtained from 
RESULTS
Baseline porcine characteristics
The baseline characteristics of the 15 mini-pigs who underwent left hepatectomy are shown in (Fig. 3) . During subgroup analysis according to time periods, blood loss at 0-5 minutes and 7-9 minutes was significantly different between groups at both 0-5 minutes and 7-9 minutes. Median blood loss at 0-5 minutes was as follows: control group 44.15 g; reference group 25.69 g; and test group 24.50 g (p=0.009). At 7-9 minutes, the median blood loss was as follows: control group 4.14 g; reference group 3.00 g; and test group 2.01 g (p=0.006) ( Table 2 ). 
Changes in laboratory parameters after liver resection
Data are number (%). Group A: control group; Group B: reference group; Group C: test group. POD, postoperative day (Table 3) .
Necropsy and histopathological findings
During necropsy, no hematomas, granulomas, or adhesions were observed in any group. In reference and test group, foreign body material noted in the postoperative day #28 pigs were not observed in the postoperative day #42 mini-pigs (Table 4) . Histopathological analysis revealed no changes suggesting toxicity related to the hemostatic agents in either reference or test group (Table 5) .
DISCUSSION
Several hemostatic agents can overcome the unsatisfactory hemostatic effects of woven cotton gauze.
Because the ideal hemostatic material should have ample hemostatic action, minimal tissue reactivity, low cost, in vivo biodegradability, and lack of antigenicity, analyses of the clinical benefits and risks of such materials should be performed by considering these qualities as standards. 8 Since ORC was first described in 1943, numerous studies have shown the hemostatic effects of ORC, including when used for hepatectomy. [9] [10] [11] In addition to its application in laparotomy or laparoscopic surgery, ORC is now also used for hemostasis during endoscopic procedures. 12 The results of the current study were similar to those pre- Because the presence of a foreign body increases the susceptibility to infection, most local hemostatic agents may increase infection and should not be used in an infected wound. 13, 14 However, ORC is resistant to infection because its acidic pH is fatal to bacteria. 15 In the current study, laboratory parameters that suggest the presence of an infection, such as WBC and CRP, showed no sig-nificant preoperative to postoperative change. In addition, abscess or other infectious changes were absent at necropsy. This result, therefore, suggests that SurgiGuard ® was not toxic to the host cells.
Healing quality is also important after the implantation of any medical material or device, and minimum inflammation without a strong foreign body reaction or inhibition of the healing process is desirable. The anti-adhesive effectiveness of ORC is previously reported. 16, 17 To improve upon this characteristic, a novel agent, Interceed ® , was developed and used for various types of surgery, especially gynecologic operations. 18, 19 Although microscopic examination revealed chronic inflammatory changes at the liver surface in the current study, no adhesions were observed around the liver on gross examination during necropsy.
ORC reportedly dissolves promptly in various sites without toxicity, with complete dissolution by 6 weeks. 6, 20 Migrated ORC is occasionally mistaken for abscess formation or leads to severe complications; hence, complete dissolution without migration is important. 21, 22 In our current study, foreign body materials were found attached to the liver at 4 weeks, but none were observed during the 6-week necropsy examinations; in addition, there was no significant difference in LFT at the time of the necropsy examinations. Although changes in LFT exhibited significant differences on postoperative day #7, the changes were possibly due to transient effects of liver resection and not from ORC toxicity. This result suggested that SurgiGuard ® has a suitable capacity for dissolving in a reasonable time without toxicity and for adhering only to surfaces to which it is applied, but not to other organs.
This study has the major limitation of the small size of the experimental groups, which potentially influenced the evaluation of statistically significant outcomes. The difficulty of creating equivalent conditions is another limitation of this study. Although there were no significant differences in PLT counts preoperatively between groups, and the resected liver weights were relatively similar between groups, this does not necessarily guarantee that each mini-pig had similar hemostatic status or resected liver margin area. Moreover, compared to other organs such as the spleen and kidney, the liver has variable spontaneous clotting times and rates of hemorrhage, which leads to difficulties in obtaining precise measurement values. 8 Nevertheless, SurgiGuard ® exhibited significant hemostatic effects compared to the control group, which were equivalent to the effects exhibited by the reference agent. Furthermore, no toxic changes and adhesions to other organs were observed at the resection margin during the entire experimental period in mini-pigs who were treated with SurgiGuard ® .
In conclusion, the current study suggested that the novel ORC, SurgiGuard ® , could be as effective as Surgicel ® in achieving hemostasis after porcine liver resection. To overcome the limitations of this study, future studies should be performed to provide more data regarding systemic environment such as similar hemostatic condition and obtaining similar resection margin.
